文献速递主动脉疾病

市售覆膜支架行肾下腹主动脉瘤腔内修复的长期结局

Long-term outcomes of infrarenal endovascular aneurysm repair with a commercially available stent graft.
PubMed 文献 · J Vasc Surg · 2019-12-30

该回顾性研究纳入1998至2012年接受择期肾下腹主动脉瘤腔内修复(EVAR)并使用单一市售覆膜支架系统的543例患者,评估其长期结果。中位影像随访5.0年,10年免于再干预率为72±3%,原发和继发临床成功率分别为58±3%和78±2%。结论认为在瘤颈解剖条件良好时,单支架系统EVAR具有可持续的长期结果,但10年总体生存率较低。

要点

  • 择期肾下EVAR使用单一覆膜支架系统10年免于再干预率为72±3%。
  • 10年原发和继发临床成功率分别为58±3%和78±2%。
  • 瘤颈解剖良好与更高的临床成功率和更低的动脉瘤相关死亡率相关。

核心结论

  • 择期肾下EVAR治疗无症状腹主动脉瘤并使用单一覆膜支架系统具有可持续的长期结果,尤其在瘤颈解剖良好时。
  • 动脉瘤相关死亡和转为开放手术非常罕见,但10年后总体生存率相当低。
  • 大多数持续临床失败的患者未接受再干预,原因包括不适合手术、拒绝或病变稳定轻微。

研究设计与样本

  • 回顾性分析1998至2012年间接受择期肾下EVAR并使用单一覆膜支架系统的患者,登记术前、术中及术后数据并复习所有影像。
  • 共纳入543例患者,其中男性476例,年龄中位数74岁(四分位距69-79岁)。

主要发现

  • 技术成功率为96.1%(522/543),围手术期死亡8例(1.5%)。
  • 中位影像随访5.0年(四分位距2.8-8.0年),10年免于再干预率为72±3%。
  • 10年原发和继发临床成功率分别为58±3%和78±2%。
  • 10年免于晚期动脉瘤相关死亡率为96±1%,总体生存率为32±2%。
  • 晚期持续继发临床失败发生于77例(14.2%)患者,其中83.1%未接受再干预。

关键数值与推荐

  • 瘤颈解剖良好在研究后半期更常见,并与更少近端术中辅助操作相关。
  • 瘤颈解剖良好与更高的原发和继发临床成功率相关(P = .001和P < .0001)。
  • 瘤颈解剖良好与更高的原发和辅助免于I/III型内漏率相关(P = .002和P < .0001),并与更低的动脉瘤相关死亡率相关(P = .008)。

临床怎么用

  • 对于解剖条件良好(尤其瘤颈)的无症状肾下腹主动脉瘤患者,择期EVAR使用单一覆膜支架系统可获得可持续的长期结果。
  • 应重视患者选择,瘤颈解剖良好者可能获得更优的临床成功率和更低的动脉瘤相关死亡率。
  • 对持续临床失败但病变稳定轻微或不适合再干预的患者,可考虑保守观察。

局限性

  • 本研究为回顾性设计,数据来自单中心单支架系统的经验,可能存在选择偏倚。
  • 原文未报告多变量校正分析,瘤颈解剖与结局的关联可能受混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the long-term results of elective abdominal aortic aneurysm (AAA) repair with a single stent graft system. METHODS: Patients undergoing elective, infrarenal endovascular aneurysm repair (EVAR) with a single-stent graft system between 1998 and 2012 were analyzed retrospectively registering pre-, intra-, and postoperative data. All imaging was reviewed. Data are presented as median and interquartile range unless otherwise stated. RESULTS: A total of 543 patients were included (476 males; 74 [69-79] years). Technical success was achieved in 522 (96.1%) patients. Eight (1.5%) patients died perioperatively. Median imaging follow-up was 5.0 (2.8-8.0) years. Freedom from reinterventions was 72 ± 3% at 10 years. Primary and secondary clinical success rates were 58 ± 3% and 78 ± 2% at 10 years, respectively. Freedom from late AAA-related death was 96 ± 1% and overall survival was 32 ± 2% at 10 years. Late persistent secondary clinical failure occurred in 77 (14.2%) patients. Most of the patients with late failures did not undergo reinterventions (83.1%) because they were unfit (39 patients), refused (5 patients), or had stable mild findings (20 patients). Five patients were converted to open repair (most recent, 2008). Favorable neck anatomy was more common in the second half of the study and was associated with less proximal intraoperative adjuncts. Importantly, it also conferred higher primary and secondary clinical success (P = .001 and P < .0001) and primary and assisted freedom from type I/III endoleaks (P = .002 and P < .0001); along with lower AAA-related mortality rates (P = .008). CONCLUSIONS: Elective infrarenal EVAR of asymptomatic AAA with single-stent graft has sustainable long-term results, especially when the aneurysm neck anatomy is favorable. AAA-related death and conversion to open repair are very rare events, but the overall survival after 10 years is quite low. The majority of the patients with persistent failure were unfit or refused further reinterventions or had stable findings. Good patient selection and technical developments may continue to improve the results in the future.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Abdulrasak M, Sonesson B, Singh B, et al. Long-term outcomes of infrarenal endovascular aneurysm repair with a commercially available stent graft. J Vasc Surg. 2019. PMID: 31899080. doi:10.1016/j.jvs.2019.09.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。